手术后处方阿片类药物——谁的责任?

IF 1.3 Q4 CLINICAL NEUROLOGY British Journal of Pain Pub Date : 2023-02-01 DOI:10.1177/20494637231154370
Neetu Bansal
{"title":"手术后处方阿片类药物——谁的责任?","authors":"Neetu Bansal","doi":"10.1177/20494637231154370","DOIUrl":null,"url":null,"abstract":"As a surgical pharmacist on the wards, I recall numerous heart-sinking occasions reviewing the medication of patients admitted to the hospital for a different complaint but still taking opioids initially prescribed during their previous admission for surgery. The question arises repeatedly in discussions with colleagues – whose responsibility is it to deprescribe opioids commenced post-operatively? Although opioids remain themainstay of post-operative pain management following both minor and major surgical procedures, there is a lack of robust evidence-based literature to guide the optimal analgesicmedicine use (type and duration) and effective deprescribing strategies postdischarge. Opioid prescriptions after surgery are a risk factor for subsequent opioid dependence, whichmay be as high as 6.5% in previously opioid naı̈ve patients. Currently, in the UK, we lack knowledge of the true prevalence of long-term opioid use after surgery. With more complex surgical procedures being undertaken as a day case or short stay and the introduction of enhanced recovery programmes resulting in a shorter post-operative length of hospital stay, patients are no longer being fully weaned off their analgesics by the time of hospital discharge. The responsibility for managing post-operative analgesia may change hands from the surgeon to primary care without exploring the reasons for ongoing opioid therapy. Furthermore, discharging patients home with opioids poses a risk of unused opioids at home, hence the risk of illicit diversion to friends and family who may describe pain. In 2021, the UK Faculty of Pain Medicine issued guidance around the best practice of opioids and surgery. This document states that all healthcare professionals involved in surgery and peri-operative care must collaborate to ensure robust opioid stewardship. Currently, there is a lack of national guidance on perioperative opioid prescribing. Furthermore shared decision-making in healthcare has been around for a long time. Increasing evidence has shown involving patients in decisions around their care leads to positive outcomes, and it is imperative to ensure peri-operative plans are drawn up collaboratively with patients. A collaborative effort of all healthcare teams across the secondary and primary care interfaces is needed to promote opioid stewardship.The focus should be on effectivewritten communication to GPs on opioid tapering plans and any perceived problems and ensuring patients are providedwith written information in the form of leaflets/pamphlets The emphasis should also be on all healthcare teams reciting the same mantra with opioid use and ensuring appropriate review at every encounter with the patient.","PeriodicalId":46585,"journal":{"name":"British Journal of Pain","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940256/pdf/","citationCount":"0","resultStr":"{\"title\":\"Deprescribing opioids post-surgery - whose responsibility is it?\",\"authors\":\"Neetu Bansal\",\"doi\":\"10.1177/20494637231154370\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"As a surgical pharmacist on the wards, I recall numerous heart-sinking occasions reviewing the medication of patients admitted to the hospital for a different complaint but still taking opioids initially prescribed during their previous admission for surgery. The question arises repeatedly in discussions with colleagues – whose responsibility is it to deprescribe opioids commenced post-operatively? Although opioids remain themainstay of post-operative pain management following both minor and major surgical procedures, there is a lack of robust evidence-based literature to guide the optimal analgesicmedicine use (type and duration) and effective deprescribing strategies postdischarge. Opioid prescriptions after surgery are a risk factor for subsequent opioid dependence, whichmay be as high as 6.5% in previously opioid naı̈ve patients. Currently, in the UK, we lack knowledge of the true prevalence of long-term opioid use after surgery. With more complex surgical procedures being undertaken as a day case or short stay and the introduction of enhanced recovery programmes resulting in a shorter post-operative length of hospital stay, patients are no longer being fully weaned off their analgesics by the time of hospital discharge. The responsibility for managing post-operative analgesia may change hands from the surgeon to primary care without exploring the reasons for ongoing opioid therapy. Furthermore, discharging patients home with opioids poses a risk of unused opioids at home, hence the risk of illicit diversion to friends and family who may describe pain. In 2021, the UK Faculty of Pain Medicine issued guidance around the best practice of opioids and surgery. This document states that all healthcare professionals involved in surgery and peri-operative care must collaborate to ensure robust opioid stewardship. Currently, there is a lack of national guidance on perioperative opioid prescribing. Furthermore shared decision-making in healthcare has been around for a long time. Increasing evidence has shown involving patients in decisions around their care leads to positive outcomes, and it is imperative to ensure peri-operative plans are drawn up collaboratively with patients. A collaborative effort of all healthcare teams across the secondary and primary care interfaces is needed to promote opioid stewardship.The focus should be on effectivewritten communication to GPs on opioid tapering plans and any perceived problems and ensuring patients are providedwith written information in the form of leaflets/pamphlets The emphasis should also be on all healthcare teams reciting the same mantra with opioid use and ensuring appropriate review at every encounter with the patient.\",\"PeriodicalId\":46585,\"journal\":{\"name\":\"British Journal of Pain\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2023-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940256/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Pain\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/20494637231154370\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Pain","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20494637231154370","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Deprescribing opioids post-surgery - whose responsibility is it?
As a surgical pharmacist on the wards, I recall numerous heart-sinking occasions reviewing the medication of patients admitted to the hospital for a different complaint but still taking opioids initially prescribed during their previous admission for surgery. The question arises repeatedly in discussions with colleagues – whose responsibility is it to deprescribe opioids commenced post-operatively? Although opioids remain themainstay of post-operative pain management following both minor and major surgical procedures, there is a lack of robust evidence-based literature to guide the optimal analgesicmedicine use (type and duration) and effective deprescribing strategies postdischarge. Opioid prescriptions after surgery are a risk factor for subsequent opioid dependence, whichmay be as high as 6.5% in previously opioid naı̈ve patients. Currently, in the UK, we lack knowledge of the true prevalence of long-term opioid use after surgery. With more complex surgical procedures being undertaken as a day case or short stay and the introduction of enhanced recovery programmes resulting in a shorter post-operative length of hospital stay, patients are no longer being fully weaned off their analgesics by the time of hospital discharge. The responsibility for managing post-operative analgesia may change hands from the surgeon to primary care without exploring the reasons for ongoing opioid therapy. Furthermore, discharging patients home with opioids poses a risk of unused opioids at home, hence the risk of illicit diversion to friends and family who may describe pain. In 2021, the UK Faculty of Pain Medicine issued guidance around the best practice of opioids and surgery. This document states that all healthcare professionals involved in surgery and peri-operative care must collaborate to ensure robust opioid stewardship. Currently, there is a lack of national guidance on perioperative opioid prescribing. Furthermore shared decision-making in healthcare has been around for a long time. Increasing evidence has shown involving patients in decisions around their care leads to positive outcomes, and it is imperative to ensure peri-operative plans are drawn up collaboratively with patients. A collaborative effort of all healthcare teams across the secondary and primary care interfaces is needed to promote opioid stewardship.The focus should be on effectivewritten communication to GPs on opioid tapering plans and any perceived problems and ensuring patients are providedwith written information in the form of leaflets/pamphlets The emphasis should also be on all healthcare teams reciting the same mantra with opioid use and ensuring appropriate review at every encounter with the patient.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
British Journal of Pain
British Journal of Pain CLINICAL NEUROLOGY-
CiteScore
3.20
自引率
11.10%
发文量
42
期刊介绍: British Journal of Pain is a peer-reviewed quarterly British journal with an international multidisciplinary Editorial Board. The journal publishes original research and reviews on all major aspects of pain and pain management. Reviews reflect the body of evidence of the topic and are suitable for a multidisciplinary readership. Where empirical evidence is lacking, the reviews reflect the generally held opinions of experts in the field. The Journal has broadened its scope and has become a forum for publishing primary research together with brief reports related to pain and pain interventions. Submissions from all over the world have been published and are welcome. Official journal of the British Pain Society.
期刊最新文献
What influences post-operative opioid requirements for tibial fractures? Botulinum toxin: Should we reconsider its place in the treatment of neuropathic pain? Experience of compassion-based practice in mindfulness for health for individuals with persistent pain. Prehabilitation: The underutilised weapon for chronic pain management. The interaction between psychological factors and conditioned pain modulation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1